Healthcare service provider Envision Healthcare (EVHC) announced its agreement to be acquired by KKR (KKR) last week. Following this news, its stock rose ~2.4% to close at $44.67 on June 15. We’ll discuss further details of the transaction in the next article.
The above chart shows analysts’ recommendations for Envision Healthcare over the last 12 months. Envision Healthcare stock has fallen ~22.6% over the last 12 months but has risen 29.3% year-to-date.
Of the 13 analysts tracking Envision Healthcare stock on June 18, two recommend “strong buy,” one recommends “buy,” and ten recommend “hold.” As shown in the chart above, their recommendations changed substantially between May and June due to the acquisition agreement. Analysts’ consensus rating for Envision is 2.6, which suggests “buy” for value investors. Notably, the Health Care Select Sector SPDR ETF (XLV) invests 0.2% of its holdings in Envision Healthcare (EVHC), 2.1% in CVS Health (CVS), and 7.4% in UnitedHealth Group (UNH).
Check out all the data we have added to our quote pages. Now you can get a valuation snapshot, earnings and revenue estimates, and historical data as well as dividend info. Take a look!